Alcami Carolinas Corporation

Form 483 issued March 13, 2023 · Morrisville, North Carolina

Inspection
Mar 1 – Mar 13, 2023
Observations
2
Pages
3
FEI number
1000158582

In short: On March 13, 2023, FDA issued a Form 483 with 2 observations to Alcami Carolinas Corporation in Morrisville, North Carolina (FEI 1000158582) after an inspection that ran Mar 1 – Mar 13, 2023. The investigator was Patty P. Kaewussdangkul. Most observations concern quality system and laboratory controls; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Quality system and laboratory controls account for 2 of 2 observations.

Quality system1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

  2. 02

    Drug product samples are…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Alcami Carolinas Corporation?

FDA listed 2 observations on this Form 483, mostly about quality system and laboratory controls. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Alcami Carolinas Corporation?

Patty P. Kaewussdangkul is named on this Form 483, for the inspection of Mar 1 – Mar 13, 2023. Each investigator has a profile showing what they cite most.

When was Alcami Carolinas Corporation inspected by FDA?

The inspection ran Mar 1 – Mar 13, 2023, and the Form 483 is dated March 13, 2023.

How do I get the full Form 483 for Alcami Carolinas Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free